1. Home
  2. CTKB vs NXP Comparison

CTKB vs NXP Comparison

Compare CTKB & NXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$5.04

Market Cap

652.1M

Sector

Health Care

ML Signal

HOLD

Logo Nuveen Select Tax Free Income Portfolio

NXP

Nuveen Select Tax Free Income Portfolio

HOLD

Current Price

$13.96

Market Cap

743.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTKB
NXP
Founded
1990
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
652.1M
743.2M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CTKB
NXP
Price
$5.04
$13.96
Analyst Decision
Hold
Analyst Count
4
0
Target Price
$5.88
N/A
AVG Volume (30 Days)
1.2M
70.0K
Earning Date
11-05-2025
01-01-0001
Dividend Yield
N/A
4.04%
EPS Growth
N/A
N/A
EPS
N/A
0.54
Revenue
$196,828,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.62
N/A
P/E Ratio
N/A
$26.81
Revenue Growth
N/A
N/A
52 Week Low
$2.37
$12.91
52 Week High
$7.30
$14.89

Technical Indicators

Market Signals
Indicator
CTKB
NXP
Relative Strength Index (RSI) 53.03 26.56
Support Level $4.71 $14.06
Resistance Level $5.13 $14.19
Average True Range (ATR) 0.20 0.10
MACD -0.00 -0.03
Stochastic Oscillator 79.20 2.27

Price Performance

Historical Comparison
CTKB
NXP

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About NXP Nuveen Select Tax Free Income Portfolio

Nuveen Select Tax Free Income Portfolio is a closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax, consistent with preservation of capital. The fund invests a majority of its assets in municipal securities and other related investments, the income from which is exempt from regular federal income tax and federal alternative minimum tax.

Share on Social Networks: